PPARγ Agonist Beyond Glucose Lowering Effect-Reference-Cited by-同舟云学术

PPARγ Agonist Beyond Glucose Lowering Effect

Published:2011 Issue:1 Volume:26 Page:19
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Sugawara Akira¹,Uruno Akira²,Kudo Masataka³,Matsuda Ken³,Yang Chul Woo⁴,Ito Sadayoshi³

Affiliation:

1. Department of Advanced Biological Sciences for Regeneration, Tohoku University Graduate School of Medicine, Sendai, Japan.

2. Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.

3. Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

4. Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea School of Medicine, Seoul, Korea.

Publisher

Korean Association of Internal Medicine

Link

http://synapse.koreamed.org/pdf/10.3904/kjim.2011.26.1.19

Reference44 articles.

1. Peroxisome Proliferator-Activated Receptors: From Genes to Physiology

2. Peroxisome proliferator-activated receptors and the vascular system: beyond their metabolic effects

3. Effects of PPAR.GAMMA. on hypertension, atherosclerosis, and chronic kidney disease

4. Actions of Peroxisome Proliferator–Activated Receptors–γ Agonists Explaining a Possible Blood Pressure–Lowering Effect

5. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PPARγ in Atherosclerotic Endothelial Dysfunction: Regulatory Compounds and PTMs;International Journal of Molecular Sciences;2023-09-24

2. The preventive effect of low-dose aspirin in a PPAR-γ antagonist treated mouse model of preeclampsia;BMC Pregnancy and Childbirth;2022-07-29

3. Crosstalk relationship between adiponectin receptors, PPAR-γ and α-adrenoceptors in renal vasculature of diabetic WKYs;European Journal of Pharmacology;2022-02

4. Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence;International Journal of Molecular Sciences;2019-10-11

5. Notoginsenoside Fc attenuates high glucose-induced vascular endothelial cell injury via upregulation of PPAR-γ in diabetic Sprague–Dawley rats;Vascular Pharmacology;2018-10